• Aucun résultat trouvé

[PDF] Top 20 Variations in the metabolome in response to disease activity of rheumatoid arthritis

Has 10000 "Variations in the metabolome in response to disease activity of rheumatoid arthritis" found on our website. Below are the top 20 most common "Variations in the metabolome in response to disease activity of rheumatoid arthritis".

Variations in the metabolome in response to disease activity of rheumatoid arthritis

Variations in the metabolome in response to disease activity of rheumatoid arthritis

... is the first study describing metabolic profiling in response to anti-TNF treatments using plasma ...samples. The study highlighted two different metabolic profiles splitting good ... Voir le document complet

8

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

... Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task ...Impact of a nurse-led programme on comorbidity management and ... Voir le document complet

5

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry

... 13 The methodology of the registry has been previously ...13 The registry was approved by the French authorities (‘Comité Consultatif sur le Traitement de l’information en matière de ... Voir le document complet

7

Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort' - authors' reply

Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort' - authors' reply

... not to determine whether the serum adipokine level might reflect RA disease activity cross-sectionally, but was to find surrogate markers able to predict structural radiographic ... Voir le document complet

3

Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls

Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls

... limitations to this study. First, although 89% of subjects have a primary physician in our health care system, the system is not closed and incomplete capture of patient information, ... Voir le document complet

17

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

... change in (A) GLOESS and the component scores for metacarpophalangeal joints 2 –5, (B) GLOESS for the 22-paired joint set, (C) GLOESS for the reduced (nine-paired) joint set and (D) DAS28 ... Voir le document complet

7

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

... factor of persistent remission and that DAS corre- lates with radiological progression ...parameter in daily clinical practice as a treatment goal and to evaluate the actual disease ... Voir le document complet

9

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

... treatment response or a favourable disease activity state, should be evaluated using vali- dated instruments providing results that are consistent through- out a de fined range and that do not favour ... Voir le document complet

5

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use

... case of certolizumab adminis- tration as rescue therapy in the third pregnancy trimester of an IBD patient had a favourable outcome [ 100 ...review of more than 120 000 adverse events ... Voir le document complet

14

Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?

Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?

... Capacities of FLS and MSC in Rheumatoid Arthritis FLS long-term survival potential is related to their low apoptosis rate and high proliferative ...Inhibition of apoptosis ... Voir le document complet

12

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study

... methodology of these registries has been ...wanted to compare the three drugs. Briefly, the French Society of Rheumatology sent regular mail and “push” emails to all French ... Voir le document complet

13

Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study

Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study

... and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA ...study. Arthritis Res Ther 2009;11: ...for ... Voir le document complet

15

Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response

Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response

... report of serious adverse events besides some immediate type I hypersensitivity (pruritis, rash, fever) in <15% of patients ( 21 ...evaluated the safety and efficacy of the ... Voir le document complet

12

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

... and disease evolution are de- scribed with mean ± SD or frequency (%) as ...and disease course were com- pared between good or moderate EULAR responders and non-responders by the Mann-Whitney U test ... Voir le document complet

9

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

... RA The 2010 ACR/EULAR classification criteria for RA incorporated criteria that can be applied to the target population mentioned above, that is, patients with the presence of obvious ... Voir le document complet

9

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

... number of strengths, and especially the use of a replication cohort, this study has several ...needs the use of an accur- ate assay such as the Quantikine kit, but the ... Voir le document complet

9

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

... reflect the patient ’s perspective and are used in rheumatoid arthritis (RA) routine clinical ...one of the most widely used PROs in RA practice and research and is ... Voir le document complet

12

Association Study of VDR Gene with Rheumatoid Arthritis in the French Population

Association Study of VDR Gene with Rheumatoid Arthritis in the French Population

... 601C), the 265-bp amplified fragment was digested with FokI, generating two fragments of 196 and 69 bp when the FokI restriction site is ...examining the BsmI polymorphism (annealing ... Voir le document complet

5

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study

... Acceptance of the Use of an Activity Tracker Finally, this study demonstrated the feasibility of wearing a mobile device over 3 months in patients with inflammatory joint ... Voir le document complet

16

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis.

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis.

... and the S 3P /L lowest risk genotype (OR ...remains to be established. This would pro- vide major clues that may help in deciphering the genetic component of RA, if significant ... Voir le document complet

7

Show all 10000 documents...